Bis(2-carboxyphenyl) succinate (disalicylic acid; DSA) is composed of two salicylic acids connected by a succinyl linker. Here, we propose its use as a new, synthetic plant-protection agent. DSA was shown to control , an emerging soft-rot pathogen of potato and ornamental crops, at minimal inhibitory concentrations (MIC) lower than those of salicylic acid. Our computational-docking analysis predicted that DSA would inhibit the quorum-sensing (QS) synthase of ExpI more strongly than SA would. In fact, applying DSA to inhibited its biofilm formation, secretion of plant cell wall-degrading enzymes, motility and production of acyl-homoserine lactones (AHL) and, subsequently, impaired its virulence. DSA also inhibited the production of AHL by a QS-negative strain (DH5α) that had been transformed with AHL synthase, as demonstrated by the biosensors CV026 and pSB401. Inhibition of the QS machinery appears to be one of the mechanisms by which DSA inhibits specific virulence determinants. A new route is proposed for the synthesis of DSA, which holds greater potential for use as an anti-virulence agent than its precursor SA. Based on these findings, DSA is an excellent candidate for repurposing for new applications.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784377 | PMC |
http://dx.doi.org/10.3390/microorganisms10122516 | DOI Listing |
Front Chem
November 2024
Medicinal Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt.
Front Chem
June 2024
Medicinal Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt.
DNA gyrase and topoisomerase IV show great potential as targets for antibacterial medicines. In recent decades, various categories of small molecule inhibitors have been identified; however, none have been effective in the market. For the first time, we developed a series of disalicylic acid methylene/Schiff bases hybrids () to act as antibacterial agents targeting DNA gyrase and topoisomerase IV.
View Article and Find Full Text PDFAm J Physiol Heart Circ Physiol
August 2024
Noll Laboratory, Department of Kinesiology, The Pennsylvania State University, University Park, Pennsylvania, United States.
The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function.
View Article and Find Full Text PDFTop Spinal Cord Inj Rehabil
January 2024
The Miami Project to Cure Paralysis, Miller School of Medicine, University of Miami, Miami, Florida.
Objectives: To investigate the effects of salsalate on fasting and postprandial (PP) glycemic, lipidemic, and inflammatory responses in persons with tetraplegia.
Methods: This study was a randomized, double-blind, cross-over design. It was conducted at a university laboratory.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!